IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tri Locum Partners LP

Q1 2026 Holdings

Filed 2026-05-18 | 17 holdings | $712.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Johnson & Johnson(JNJ)COM478160104$101.3M414,50314.2%
Intuitive Surgical Inc(ISRG)COM NEW46120E602$70.6M153,2509.9%
Thermo Fisher Scientific Inc(TMO)COM883556102$65.1M132,4139.1%
Ascendis Pharma A/S(ASND)SPONSORED ADR04351P101$58.4M255,3328.2%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$57.7M129,3148.1%
ELI Lilly & Co(LLY)COM532457108$56.8M61,7958.0%
Madrigal Pharmaceuticals Inc(MDGL)COM558868105$54.1M103,2887.6%
Dexcom Inc(DXCM)COM252131107$43.8M698,1586.2%
United Therapeutics Corp del(UTHR)COM91307C102$41.7M70,3705.9%
Nuvalent Inc(NUVL)COM670703107$31.6M308,5064.4%
Teva Pharmaceutical Inds LTD(TEVA)SPONSORED ADS881624209$30.8M1,021,0084.3%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$30.0M158,6634.2%
Argenx SE(ARGX)SPONSORED ADR04016X101$23.1M31,6353.2%
Tarsus Pharmaceuticals Inc(TARS)COM87650L103$17.7M252,5882.5%
Dianthus Therapeutics Inc(DNTH)COM252828108$12.2M145,5431.7%
Axsome Therapeutics Inc.(AXSM)COM05464T104$10.5M62,1161.5%
Definium Therapeutics Inc(DFTX)COM SHS24477V105$7.0M369,5881.0%